926345

NanoFabTx^™-DC-Chol Lipid Mix

for synthesis of cationic (DC-cholesterol) liposomes

• UNSPSC-Code: 12162002
• NACRES: NA.23

Eigenschaften

• Qualitätsniveau: 100
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

NanoFabTx^™-DC-Chol Lipid Mix; for synthesis of cationic (DC-cholesterol) liposomes is a ready-to-use nanoformulation blend for the synthesis of liposomes for drug delivery. The NanoFabTx^™-DC-Chol Lipid Mix includes optimized protocols with step-by-step instructions for synthesizing cationic DC-cholesterol liposomes for drug delivery applications. The modification of the liposomes with the cationic lipid, DC-cholesterol, have numerous advantages including high gene transfection efficiency. Liposome-based formulations are widely used for drug delivery applications and enable improved therapeutic efficacy of a range of drug types including small molecules, nucleic acids, proteins, and peptides.

Anwendung

About NanoFabTx^™

NanoFabTx^™ lipid mixes and formulation kits enable users to encapsulate a wide variety of therapuetic drug molecules for targeted or extended drug delivery without the need for lengthy trial-and-error optimization. NanoFabTx^™ reagent kits provide an easy-to-use toolkit for encapsulating a variety of therapeutics in nanoparticles, microparticles, or liposomes. Drug encapsulated particles synthesized with the NanoFabTx^™ kits are suitable for biomedical research applications such as oncology, immuno-oncology, gene delivery, and vaccine delivery.

Leistungsmerkmale und Vorteile

• A ready-to-use nanoformulation blend for the synthesis of cationic DC-cholesterol liposomes
• Step-by-step protocols (extrusion or microfluidic) developed and tested by our formulation scientists
• Flexible synthesis tools to create uniform and reproducible liposomes
• Optimized to make liposomes around 100 nm with low polydispersity
• DC-Cholesterol allows for high transfection efficiency and targeted drug delivery

Comprehensive protocols for liposome synthesis are included:

• A lipid film hydration and extrusion protocol.
• A microfluidics protocol using commercial platforms or syringe pumps.

The microfluidics protocol included with this product uses the NanoFabTx^™ device kit (911593). These kits are ready-to-use and include the microfluidic chip, fittings, and tubing required for microfluidics-based synthesis (compatible microfluidics system or syringe pump required).

Rechtliche Hinweise

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3